Oncolytics Biotech, Inc. Share Price
NASDAQ: ONCY | Micro CapOncolytics Biotech, Inc. Stock Performance
Oncolytics Biotech, Inc. Share Price Today
As of 30 October 2026, Oncolytics Biotech, Inc.'s share price is $0.43. The stock opened at $0.44, compared to its previous close of $0.44. During today's trading session, Oncolytics Biotech, Inc.'s share price traded between $0.43 and $0.45, with an average price of $0.44. Over the past 52 weeks, the stock has recorded a high of $1.30 and a low of $0.43. In terms of performance, Oncolytics Biotech, Inc.'s share price has declined by 52.36% over the last six months and is down 63.94% on a year-on-year basis.
Oncolytics Biotech, Inc. Share Price Chart
Oncolytics Biotech, Inc. Quarterly Profit & Loss
All figures in USD
Oncolytics Biotech, Inc. Annual Profit & Loss
All figures in USD
About Oncolytics Biotech, Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Oncolytics Biotech, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.63 | $0.43 | -35.50% |
Sep 2026 | $0.83 | $0.66 | -22.21% |
Aug 2026 | $0.75 | $0.85 | +14.08% |
Jul 2026 | $0.93 | $0.75 | -20.97% |
Jun 2026 | $1.16 | $0.94 | -10.10% |
May 2026 | $0.91 | $1.05 | +17.06% |
Apr 2026 | $0.85 | $0.90 | +5.16% |
Mar 2026 | $1.11 | $0.85 | -24.18% |
Feb 2026 | $0.98 | $1.13 | +14.21% |
Jan 2026 | $0.91 | $0.98 | +13.87% |
Dec 2025 | $0.99 | $0.86 | -12.63% |
Nov 2025 | $1.17 | $0.99 | -16.46% |